Minnesota’s Synovis Life Technologies Inc. is being acquired by Baxter International Inc. in a $325 million deal, the companies announced today.Synovis’ board unanimously approved the buy at $28 per share. Pending shareholder approval, the deal is expected to close in the first quarter of 2012.The maker of biological and mechanical products for surgeries generated $68.6 [...]

Synovis Life Technologies Inc. announced Wednesday that the company had both top-line and bottom-line growth in its fiscal second quarter ended April 30.The St. Paul, Minnesota-based company saw revenue climb 12.6 percent to $19.8 million in the quarter, up from $17.6 million in the same quarter a year ago. Profits jumped 57.5 percent to $2 [...]

Synovis Life Technologies Inc. (NASDAQ:SYNO) may not have generated many headlines this year (which is not necessarily a bad thing), but the St. Paul company has quietly produced a rather impressive annual performance, especially compared to what remains of Minnesota’s shrinking, publicly traded medical device sector.

Ernie Andberg has a little more free time on his hands these days.The long-time “emerging medical device companies” equity analyst for Feltl & Co. in Minneapolis has not seen a lot of companies emerging lately.In fact, they’ve been disappearing all together. Case in point: Medtronic Inc.’s (NYSE: MDT) deal last week to acquire ATS Medical [...]

Device maker Synovis Life Technologies Inc. said its board of directors has authorized the company to repurchase up to 1 million shares of its common stock.Synovis’ board gave it plenty of leeway for the buyback. There’s no expiration date and no minimum purchase amount, according to a statement from the company.The company seeks to buy [...]

Synovis Life Technologies Inc. has received clearance from the U.S. Food and Drug Administration for a device that measures blood flow immediately after surgical procedures in which veins have been connected.